SGIOY
Price
$8.35
Change
+$0.02 (+0.24%)
Updated
Jul 16 closing price
Capitalization
12.4B
11 days until earnings call
TAK
Price
$14.74
Change
+$0.02 (+0.14%)
Updated
Jul 17, 04:59 PM (EDT)
Capitalization
43.11B
13 days until earnings call
Interact to see
Advertisement

SGIOY vs TAK

Header iconSGIOY vs TAK Comparison
Open Charts SGIOY vs TAKBanner chart's image
Shionogi & Co
Price$8.35
Change+$0.02 (+0.24%)
Volume$97.47K
Capitalization12.4B
Takeda Pharmaceutical
Price$14.74
Change+$0.02 (+0.14%)
Volume$43.52K
Capitalization43.11B
SGIOY vs TAK Comparison Chart in %
Loading...
SGIOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SGIOY vs. TAK commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SGIOY is a Buy and TAK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 18, 2025
Stock price -- (SGIOY: $8.35 vs. TAK: $14.72)
Brand notoriety: SGIOY and TAK are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: SGIOY: 130% vs. TAK: 157%
Market capitalization -- SGIOY: $12.4B vs. TAK: $43.11B
SGIOY [@Pharmaceuticals: Other] is valued at $12.4B. TAK’s [@Pharmaceuticals: Other] market capitalization is $43.11B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SGIOY’s FA Score shows that 2 FA rating(s) are green whileTAK’s FA Score has 2 green FA rating(s).

  • SGIOY’s FA Score: 2 green, 3 red.
  • TAK’s FA Score: 2 green, 3 red.
According to our system of comparison, SGIOY is a better buy in the long-term than TAK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SGIOY’s TA Score shows that 5 TA indicator(s) are bullish while TAK’s TA Score has 3 bullish TA indicator(s).

  • SGIOY’s TA Score: 5 bullish, 3 bearish.
  • TAK’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, SGIOY is a better buy in the short-term than TAK.

Price Growth

SGIOY (@Pharmaceuticals: Other) experienced а -0.80% price change this week, while TAK (@Pharmaceuticals: Other) price change was -2.71% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.83%. For the same industry, the average monthly price growth was +5.67%, and the average quarterly price growth was +73.81%.

Reported Earning Dates

SGIOY is expected to report earnings on Oct 27, 2025.

TAK is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.83% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TAK($43.1B) has a higher market cap than SGIOY($12.4B). TAK has higher P/E ratio than SGIOY: TAK (36.79) vs SGIOY (9.62). SGIOY YTD gains are higher at: 19.973 vs. TAK (11.178). TAK has higher annual earnings (EBITDA): 1.01T vs. SGIOY (242B). SGIOY has more cash in the bank: 563B vs. TAK (317B). SGIOY has less debt than TAK: SGIOY (9.41B) vs TAK (4.66T). TAK has higher revenues than SGIOY: TAK (4.17T) vs SGIOY (427B).
SGIOYTAKSGIOY / TAK
Capitalization12.4B43.1B29%
EBITDA242B1.01T24%
Gain YTD19.97311.178179%
P/E Ratio9.6236.7926%
Revenue427B4.17T10%
Total Cash563B317B178%
Total Debt9.41B4.66T0%
FUNDAMENTALS RATINGS
SGIOY vs TAK: Fundamental Ratings
SGIOY
TAK
OUTLOOK RATING
1..100
6653
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
10
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
285
PRICE GROWTH RATING
1..100
5255
P/E GROWTH RATING
1..100
4317
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TAK's Valuation (10) in the Pharmaceuticals Major industry is in the same range as SGIOY (26) in the null industry. This means that TAK’s stock grew similarly to SGIOY’s over the last 12 months.

TAK's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as SGIOY (100) in the null industry. This means that TAK’s stock grew similarly to SGIOY’s over the last 12 months.

SGIOY's SMR Rating (2) in the null industry is significantly better than the same rating for TAK (85) in the Pharmaceuticals Major industry. This means that SGIOY’s stock grew significantly faster than TAK’s over the last 12 months.

SGIOY's Price Growth Rating (52) in the null industry is in the same range as TAK (55) in the Pharmaceuticals Major industry. This means that SGIOY’s stock grew similarly to TAK’s over the last 12 months.

TAK's P/E Growth Rating (17) in the Pharmaceuticals Major industry is in the same range as SGIOY (43) in the null industry. This means that TAK’s stock grew similarly to SGIOY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SGIOYTAK
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
61%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
44%
Momentum
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
49%
MACD
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
50%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
49%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
42%
Advances
ODDS (%)
Bullish Trend 8 days ago
64%
Bullish Trend 18 days ago
43%
Declines
ODDS (%)
Bearish Trend 10 days ago
59%
Bearish Trend 2 days ago
45%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
71%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
41%
View a ticker or compare two or three
Interact to see
Advertisement
SGIOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
JPRE48.020.46
+0.97%
JPMorgan Realty Income ETF
SLYG89.990.70
+0.78%
SPDR® S&P 600 Small Cap Growth ETF
DVSP23.830.13
+0.53%
WEBs Defined Volatility SPY ETF
IOCT32.550.08
+0.24%
Innovator Intl Dev Pwr Bffr ETF™ - Oct
NBDS34.03N/A
N/A
Neuberger Berman Disrupters ETF

SGIOY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGIOY has been loosely correlated with TAK. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if SGIOY jumps, then TAK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGIOY
1D Price
Change %
SGIOY100%
+0.24%
TAK - SGIOY
40%
Loosely correlated
-0.20%
ESAIY - SGIOY
36%
Loosely correlated
+0.76%
KMDA - SGIOY
27%
Poorly correlated
N/A
SCYX - SGIOY
23%
Poorly correlated
N/A
SUPN - SGIOY
22%
Poorly correlated
+0.03%
More

TAK and

Correlation & Price change

A.I.dvisor indicates that over the last year, TAK has been loosely correlated with SGIOY. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TAK jumps, then SGIOY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TAK
1D Price
Change %
TAK100%
-0.20%
SGIOY - TAK
41%
Loosely correlated
+0.24%
HLN - TAK
37%
Loosely correlated
-0.41%
ESAIY - TAK
35%
Loosely correlated
+0.76%
BNXTF - TAK
32%
Poorly correlated
+0.75%
EOLS - TAK
27%
Poorly correlated
-0.76%
More